OC-0086: A Sarcoma Hypoxia Signature (nanostring® Assay) Validates in the Phase III VorteX Radiotherapy TrialL. Forker,B. Bibby,L. Yang,J. Irlam,H. Valentine,P. Shenjere,J. Wylie, M. Leahy,P. Gaunt,L. Billingham,M. Robinson,A. Choudhury,C. WestRADIOTHERAPY AND ONCOLOGY（2020）引用 0|浏览23AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
